Newsroom

Categories: COVID-19, Clinical Research & Trials, Corporate, Finance & Investor

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

August 16, 2023

Categories: Healthcare, COVID-19, Drug Discovery & Development

PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases

July 18, 2023

Categories: Biotechnology, COVID-19, Corporate, Finance & Investor

Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections

September 6, 2022

Categories: Healthcare, COVID-19

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions announce a new antibody cocktail effective against major variants of SARS-CoV-2

June 7, 2022

Categories: Biotechnology, Healthcare, COVID-19

DOLPHIN Vagus Stimulation receives Health Canada Approval for covid-19 (ARDS)

February 9, 2022

Categories: Healthcare, COVID-19

Labs Evidence : Novel Concepts Medical blocked Omicron and Coronavirus entry to human cells

February 9, 2022

Categories: COVID-19, Clinical Research & Trials

Novel Concepts Medical groundbreaking medicine successfully disrupted COVID-19 spike protein attachment into host cells, intended to stop Omicron

December 16, 2021

Categories: Biotechnology, COVID-19, Microbiology & Infection Control

Hyris fully embraces the Immunology sector to better fight COVID-19 and beyond, presenting its new, disruptive T-Cell test to the international conference "A-Wish"

December 15, 2021

Categories: Healthcare, COVID-19, biopharma

Noorik Biopharmaceuticals announces the signing of a development contract with the Federal Government of Switzerland to develop ambrisentan as a treatment for severe COVID-19

December 15, 2021